Get the app
USHealthcare

The Ensign Group Inc (ENSG)

US · Healthcare · Medical Care Facilities

$174.92-1.65%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$1.44B
Revenue YoY
+17.3%
Net profit
$99.7M
Profit YoY
+18.2%
EPS
$1.72
EPS estimate
$1.63
Net margin
6.9%

EPS came in at 1.72 against a street estimate of 1.63 — a beat of 5.5%.

Key statistics

Market cap
$10.07B
P/E
27.4
Forward P/E
20.7
P/B
4.17
Book value
$42.26
EPS (TTM)
$6.31
Dividend yield
0.15%
52-week high
$217.84
52-week low
$141.52
50-day MA
$175.34
200-day MA
$182.13
Beta
0.69

Analyst view

Analysts rate The Ensign Group Inc a buy (4 buy, 1 hold, 0 sell out of 5) with an average price target of $220.00.

Shareholding

Insiders
3.53%
Institutions
92.55%

Largest institutional holders

FundStake
BlackRock Inc12.64%
Baillie Gifford & Co Limited.8.63%
Vanguard Portfolio Management, LLC5.35%
Vanguard Capital Management, LLC4.45%
FMR Inc3.94%
Wasatch Advisors LP3.91%
State Street Corp3.54%
Capital Research Global Investors3.47%

Recent filings & reports

DocumentDate
Charter / bylaws change · Q3 2026
SUMMARY OF THE ENSIGN GROUP, INC. FORM 8-K (AUGUST 20, 2026) HEADLINE NUMBERS • No financial results provided – This is a corporate governance filin
2026-08-25
Material agreement · Q3 2026
THE ENSIGN GROUP, INC. – FORM 8-K SUMMARY HEADLINE NUMBERS • Credit facility increased by $200.0 million to total aggregate principal of $800.0 mill
2026-08-20
Quarterly report · Q2 2026
THE ENSIGN GROUP, INC. – Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Total Revenue (6 months ended June 30, 2026): $2,829.7 million, up 17.8% from $2,40
2026-07-27
Results announced · Q3 2026
THE ENSIGN GROUP, INC. – Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Q2 2026 Diluted EPS: $1.68 GAAP (up 16.7% YoY); $1.92 adjusted (up 20.8% YoY) •
2026-07-27
Company announcement · Q2 2026
THE ENSIGN GROUP, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Board of Directors approved a $60 million increase to the stock repurchase program on J
2026-06-15
Quarterly report · Q1 2026
ENSIGN GROUP, INC. — Q1 2026 10-Q SUMMARY --- HEADLINE NUMBERS • Total Revenue (Q1 2026): $1,389,196 thousand ($1.389 billion), up from $1,173,041
2026-04-30
Proxy statement · Q2 2026
THE ENSIGN GROUP, INC. — 2026 PROXY STATEMENT SUMMARY CEO COMPENSATION • Barry R. Port (CEO) total compensation: specific amount not disclosed in pr
2026-04-02
Annual report FY2025
THE ENSIGN GROUP, INC. – 10-K SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Total facilities as of December 31, 2025: 373 skilled nursing and seni
2026-02-04

Readable in the app.

Corporate actions

ActionDetailDate
Dividend$0.07 / share
ex-date Jun 30, 2026 · pay Jul 31, 2026
2026-06-30
Dividend$0.07 / share
ex-date Mar 31, 2026 · pay Apr 30, 2026
2026-03-31
Dividend$0.07 / share
ex-date Dec 31, 2025 · pay Jan 31, 2026
2025-12-31
Dividend$0.06 / share
ex-date Sep 30, 2025 · pay Oct 31, 2025
2025-09-30

Deals & corporate news

AnnouncementDate
Board approves $60 million increase to stock repurchase program
The Ensign Group's Board of Directors approved a $60 million increase to its stock repurchase program on June 12, 2026, bringing total authorized repurchase capacity from $40 million to $100
2026-06-15
Board approves $40 million stock repurchase program
The Ensign Group's Board of Directors approved a new $40 million stock repurchase program on May 13, 2026. This program will begin after the company's current repurchase program expires. The
2026-06-10

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for The Ensign Group Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Data updated 2026-09-18.